HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nadjia Kachenoura Selected Research

Nadjia Kachenoura Research Topics

Disease

3Hypertension (High Blood Pressure)
07/2021 - 01/2016
3Hypertrophy
07/2021 - 12/2015
3Chest Pain (Chest Pains)
09/2019 - 06/2017
3Pathologic Constriction (Stenosis)
09/2019 - 07/2011
2Cushing Syndrome
11/2021 - 11/2014
1Obesity
12/2021
1Cicatrix (Scar)
12/2021
1COVID-19
12/2021
1Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2021
1Vascular Remodeling
07/2021
1Thoracic Aortic Aneurysm
01/2021
1Aortic Valve Stenosis (Aortic Stenosis)
01/2021
1Hyperaldosteronism (Conn Syndrome)
10/2020
1Fibrosis (Cirrhosis)
10/2020
1Essential Hypertension
10/2020
1Atrial Fibrillation
01/2018
1Pituitary ACTH Hypersecretion
01/2017
1Coronary Artery Disease (Coronary Atherosclerosis)
07/2012
1Myocardial Infarction
10/2008

Drug/Important Bio-Agent (IBA)

4regadenosonFDA Link
09/2019 - 07/2012
2Hydrocortisone (Cortisol)FDA LinkGeneric
11/2021 - 01/2017
2Retinaldehyde (Retinal)IBA
07/2021 - 01/2016
2GadoliniumIBA
12/2015 - 10/2008
1Interleukin-6 (Interleukin 6)IBA
12/2021
1Protons (Proton)IBA
11/2021
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
11/2021
1LipidsIBA
11/2021
1N-acetylVal-Nle(7,8)- allatotropin (5-13) (ATAA)IBA
01/2021
1SaltsIBA
10/2020
1AldosteroneIBA
10/2020
1Vasodilator Agents (Vasodilators)IBA
09/2019
1Biomarkers (Surrogate Marker)IBA
01/2018
1A 7 (A-7)IBA
05/2016
1Pharmaceutical PreparationsIBA
01/2016
1Phenobarbital (Luminal)FDA Link
07/2011

Therapy/Procedure

2Aftercare (After-Treatment)
01/2017 - 11/2014
1Critical Care (Surgical Intensive Care)
12/2021
1Therapeutics
12/2021